Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection

Affiliations

¹ Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
² Department of Infectious Diseases, University Hospital of Wales, Cardiff and Vale University Health Board, Cardiff, UK.
³ Department of Intensive Care, University College London Hospital, ULCH NHS Trust, London, UK.
⁴ Department of Infectious Diseases, Chelsea and Westminster Hospital, Imperial NHS Trust, London, UK.
⁵ Faculty of Medicine, Imperial College London, London, UK.
⁶ Oxford University Clinical Academic Graduate School, University of Oxford, Oxford, UK.

Andrew Hill et al. Open Forum Infect Dis. 2022.

. 2022 Feb 5;9(3):ofac056.

doi: 10.1093/ofid/ofac056. eCollection 2022 Mar.

¹ Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
² Department of Infectious Diseases, University Hospital of Wales, Cardiff and Vale University Health Board, Cardiff, UK.
³ Department of Intensive Care, University College London Hospital, ULCH NHS Trust, London, UK.
⁴ Department of Infectious Diseases, Chelsea and Westminster Hospital, Imperial NHS Trust, London, UK.
⁵ Faculty of Medicine, Imperial College London, London, UK.
⁶ Oxford University Clinical Academic Graduate School, University of Oxford, Oxford, UK.

Abstract

[This retracts the article DOI: 10.1093/ofid/ofab358.]

Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.
Hill A, Garratt A, Levi J, Falconer J, Ellis L, McCann K, Pilkington V, Qavi A, Wang J, Wentzel H. Hill A, et al. Open Forum Infect Dis. 2021 Jul 6;8(11):ofab358. doi: 10.1093/ofid/ofab358. eCollection 2021 Nov. Open Forum Infect Dis. 2021. Retraction in: Open Forum Infect Dis. 2022 Feb 05;9(3):ofac056. doi: 10.1093/ofid/ofac056. PMID: 34796244 Free PMC article. Retracted. Review.